NovoCure (NVCR) EBT Margin Growth (1y) (2015 - 2026)
NovoCure (NVCR) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 1,524.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,524.00 |
| Mar 31, 2026 | -2,024.00 |
| Dec 31, 2025 | 1,074.00 |
| Sep 30, 2025 | -404.00 |
| Jun 30, 2025 | -691.00 |
| Mar 31, 2025 | 330.00 |
| Dec 31, 2024 | -543.00 |
| Sep 30, 2024 | 2,396.00 |
| Jun 30, 2024 | 2,765.00 |
| Mar 31, 2024 | 1,896.00 |
| Dec 31, 2023 | -345.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,618.00 |
| Mar 31, 2023 | -3,998.00 |
| Dec 31, 2022 | -615.00 |
| Sep 30, 2022 | -999.00 |
| Jun 30, 2022 | -667.00 |
| Mar 31, 2022 | 20.00 |
| Dec 31, 2021 | -2,533.00 |
| Sep 30, 2021 | -1,620.00 |